Product Information

ROFLUMILAST 500 MCG TABLET is a generic product labeled by Major Pharmaceuticals, priced at $0.3025 per EA under NDC 00904748303. Its NADAC has been published 112 times since Sep 25, 2024.

FDA first approved this application on Sep 7, 2022. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

ROFLUMILAST 500 MCG TABLET

Roflumilast
$0.3025per EA

Strength

500 ug/1

NDC

00904748303

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

ROFLUMILAST

Approval Type

Generic (ANDA)

FDA Application

ANDA208256

FDA Approved

9/7/2022

TE Code

AB

On Market Since

5/22/2024

Pharmacological Classes

Phosphodiesterase 4 Inhibitor
Phosphodiesterase 4 Inhibitors

Price Statistics

The NADAC for ROFLUMILAST 500 MCG TABLET has been published 112 times since Sep 25, 2024, and over the history we have for it it has declined 24.3%. The table below summarizes its recorded NADAC range and movement.

Current price$0.3025 per EA
All-time high$0.3994 (Oct 16, 2024)
All-time low$0.2563 (Nov 20, 2024)
52-week high$0.3445
52-week low$0.3025
Median price$0.3227
Average price$0.3319
Largest weekly change-31.1% (Nov 20, 2024)
Weeks tracked112
Tracking sinceSep 25, 2024

Price History

1W

0.0%

1M

-2.8%

3M

-3.2%

6M

-5.1%

1Y

-5.1%

3Y

N/A

5Y

N/A

All

-24.3%

Generic Alternatives

The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of ROFLUMILAST 500 MCG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for ROFLUMILAST 500 MCG TABLET, manufactured by Major Pharmaceuticals, is $0.3025 per EA (NDC 00904748303), effective Nov 11, 2026.

How has the price of ROFLUMILAST 500 MCG TABLET changed over time?

Over the history we have for it, the NADAC for ROFLUMILAST 500 MCG TABLET has declined 24.3%. It has been tracked across 112 weekly CMS publications since Sep 25, 2024.

What are the highest and lowest recorded NADAC prices for ROFLUMILAST 500 MCG TABLET?

Since Sep 25, 2024, the NADAC for ROFLUMILAST 500 MCG TABLET has ranged from a low of $0.2563 (Nov 20, 2024) to a high of $0.3994 (Oct 16, 2024), with a median of $0.3227 per EA.

Are there cheaper alternatives to ROFLUMILAST 500 MCG TABLET?

7 manufacturers publish a NADAC-priced product with the same active ingredient and strength as ROFLUMILAST 500 MCG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures ROFLUMILAST 500 MCG TABLET?

ROFLUMILAST 500 MCG TABLET (NDC 00904748303) is labeled by Major Pharmaceuticals, and CMS classifies it as a generic product.